Anti-Leukemic Activity of Axitinib Against Cells Harboring the BCR-ABL T315I Point Mutation

Journal of Hematology and Oncology - United Kingdom
doi 10.1186/s13045-015-0190-9
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy